Blood · 2011 · 40 citations · 33 references
PharmacyPharmacologyPharmacotherapyBioavailabilityClinical PharmacologyDrug InteractionsAdverse Drug Event DetectionAdverse Drug ReactionsAnticoagulant ToxicityDrug DispositionDrug-disease InteractionsPharmacoepidemiologyAcetaminophen UseAcetaminophen-alcohol InteractionsDrug Interactions In AnticoagulationWarfarin ResponseWarfarin Toxicity
Ms TS is a 66-year-old woman who receives warfarin for prevention of systemic embolization in the setting of hypertension, diabetes, and atrial fibrillation. She had a transient ischemic attack about 4 years ago when she was receiving aspirin. Her INR control was excellent; however, over the past few months it has become erratic, and her average dose required to maintain an INR of 2.0 to 3.0 appears to have decreased. She has had back pain over this same period and has been taking acetaminophen at doses at large as 650 mg four times daily, with her dose varying based on her symptoms. You recall a potential interaction and wonder if (1) her acetaminophen use is contributing to her loss of INR control, and (2) does this interaction place her at increased risk of warfarin-related complications?
33
Pharmacology and Management of the Vitamin K Antagonists
Jack Ansell, Jack Hirsh, Elaine M. Hylek et al. · CHEST Journal · 2008 · 2.1K citations
The Pharmacology and Management of the Vitamin K Antagonists
Jack Ansell, Jack Hirsh, L. Poller et al. · CHEST Journal · 2004 · 1.5K citations
Stuart J. Connolly, Janice Pogue, John W. Eikelboom et al. · Circulation · 2008 · 873 citations · Full text
Medicine, Cardiology, Pharmacology +14